Skip to main content

A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS)

Clinical Trial Grant
Duke Scholars

Administered By

Urology

Awarded By

Molecular Insight Pharmaceuticals, Inc.

Start Date

July 1, 2016

End Date

April 11, 2019
 

Administered By

Urology

Awarded By

Molecular Insight Pharmaceuticals, Inc.

Start Date

July 1, 2016

End Date

April 11, 2019